Literature DB >> 14476677

Subclinical infection of dogs by canine-adapted measles virus evidenced by their subsequent immunity to canine distemper virus.

R A MOURA, J WARREN.   

Abstract

Moura, Roberto A. (Chas. Pfizer and Company, Inc., Terre Haute, Ind.) and Joel Warren. Subclinical infection of dogs by canine-adapted measles virus evidenced by their subsequent immunity to canine distemper virus. J. Bacteriol. 82:702-705. 1961.-Young dogs were inoculated with virulent measles virus which had been adapted to canine kidney or human amnion cell culture. None of the animals showed any clinical symptoms nor could virus be isolated from the blood, although measles-neutralizing and complement-fixing antibodies developed during convalescence. All dogs failed to develop antibody to canine distemper. However, when these and normal control animals were subsequently inoculated intracerebrally with virulent distemper virus, each of the controls succumbed to typical symptoms, whereas all of the measles-immune dogs survived. These results suggest that the cross-protection conferred by measles against canine distemper virus infection involves factors other than humoral antibody. The immunity persists for a considerable length of time.

Entities:  

Keywords:  DISTEMPER/virology; MEASLES/virology

Mesh:

Year:  1961        PMID: 14476677      PMCID: PMC279238          DOI: 10.1128/jb.82.5.702-705.1961

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  7 in total

1.  Measles antibodies in the population of New Haven, Connecticut.

Authors:  F L BLACK
Journal:  J Immunol       Date:  1959-07       Impact factor: 5.422

2.  The measurement of complement fixation by viruses.

Authors:  F FULTON
Journal:  Adv Virus Res       Date:  1958       Impact factor: 9.937

3.  Canine distemper virus in the ferret.

Authors:  N M LARIN
Journal:  J Comp Pathol       Date:  1955-10       Impact factor: 1.311

4.  Encephalitis in dogs produced by distemper virus.

Authors:  J H GILLESPIE; C G RICKARD
Journal:  Am J Vet Res       Date:  1956-01       Impact factor: 1.156

5.  Propagation in tissue cultures of cytopathogenic agents from patients with measles.

Authors:  J F ENDERS; T C PEEBLES
Journal:  Proc Soc Exp Biol Med       Date:  1954-06

6.  A study of the relationship between canine distemper and measles in the dog.

Authors:  J H GILLESPIE; D T KARZON
Journal:  Proc Soc Exp Biol Med       Date:  1960-12

7.  The canine distemper-measles complex. I. Immune response of dogs to canine distemper and measles viruses.

Authors:  J WARREN; M K NADEL; E SLATER; S J MILLIAN
Journal:  Am J Vet Res       Date:  1960-01       Impact factor: 1.156

  7 in total
  4 in total

1.  Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge.

Authors:  J Taylor; S Pincus; J Tartaglia; C Richardson; G Alkhatib; D Briedis; M Appel; E Norton; E Paoletti
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Measles vaccination of nonhuman primates provides partial protection against infection with canine distemper virus.

Authors:  Rory D de Vries; Martin Ludlow; R Joyce Verburgh; Geert van Amerongen; Selma Yüksel; D Tien Nguyen; Stephen McQuaid; Albert D M E Osterhaus; W Paul Duprex; Rik L de Swart
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

3.  Human Paramyxovirus Infections Induce T Cells That Cross-React with Zoonotic Henipaviruses.

Authors:  Rory D de Vries; Alwin de Jong; R Joyce Verburgh; Lucie Sauerhering; Gijsbert P van Nierop; Robert S van Binnendijk; Albert D M E Osterhaus; Andrea Maisner; Marion P G Koopmans; Rik L de Swart
Journal:  mBio       Date:  2020-07-07       Impact factor: 7.867

4.  Probing Morbillivirus Antisera Neutralization Using Functional Chimerism between Measles Virus and Canine Distemper Virus Envelope Glycoproteins.

Authors:  Miguel Angel Muñoz-Alía; Stephen J Russell
Journal:  Viruses       Date:  2019-07-27       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.